FDA Drug Recall: LICEOUT Liquid Lice Treatment for Manufacturing Violations
Neogen Corporation voluntarily recalled 5,328 sachets of LICEOUT lice treatment due to manufacturing practice violations. The product was distributed to Bob Barker Company for institutional facilities.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA classified this as a Class II recall based on manufacturing practice violations. No illnesses or injuries have been reported in relation to this product.
Plain-English summary
Neogen Corporation has voluntarily recalled 5,328 sachets of LICEOUT Liquid Lice Treatment (NDC 53427-124-01) due to manufacturing practice violations. The recalled lot is LO09530 with an expiration date of September 5, 2025.
The recall stems from violations of Current Good Manufacturing Practice (CGMP) requirements. Neogen Corporation identified these compliance issues and initiated the recall on October 8, 2024.
The product was sold directly to Bob Barker Company, Inc., which distributes supplies to institutional facilities including correctional institutions. Those with this product should contact their healthcare provider or facility administrator for guidance.
The recalled product
- Product
- LICEOUT, Liquid Lice Treatment for Human Use, Contents: 1 FL. OZ. (29.6 mL) per sachet, Distributed By: Bob Barker Company, Inc., 7925 Purfoy Road, Fuquay-Varina, NC 27526. NDC: 53427-124-01
- Manufacturer
- Neogen Corporation
- Category
- Drug — Lice Treatment
- Hazard
- Affected units
- 5,328
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot LO09530
- Exp 9/5/2025
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Neogen Corporation under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Neogen Corporation
See all →- ModerateDrug Lice Treatment Recalled Due to Manufacturing Practice Violations
FDA (Drugs) · 2024-12-04
Same hazard · cgmp violation
See all →- Moderatevite20 Antifungal Cream recalled due to stability testing deviations
FDA (Drugs) · 2026-07-08
- ModerateNeuroquell products recalled over current good manufacturing practice violations
FDA (Drugs) · 2025-09-17
- ModerateOptim V Anti-Itch Cream Recalled for Current Good Manufacturing Practice Deviations
FDA (Drugs) · 2025-05-28
- ModerateNature Mint Anticavity Fluoride Toothpaste Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28
- ModerateRapidol Hydrocortisone 1% Anti-Itch Cream Recalled for CGMP Deviations
FDA (Drugs) · 2025-05-28